EUVIMEDEUVIMED entdecken
Open Access

Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy

Alisha Chitrakar, Scott-Wesley M Bean, Tamir Kanias iD, Kimberly A Thomas iD

Transfusion · 2024

DOI: 10.1111/trf.17926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Alisha Chitrakar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vitalant Research Institute, Denver, Colorado, USA. Hauptthemen laut MEDLINE: Testosterone, Blood Platelets, Hormone Replacement Therapy, Blood Preservation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Critical shortages in the national blood supply have led to a re‐evaluation of previously overlooked donor sources for blood products. As a part of that effort, red blood cells collected from therapeutic phlebotomy of donors on testosterone replacement therapy (TRT) have been conditionally approved for transfusion. However, platelets from TRT donors are not currently approved for use due to limited data on effects of supraphysiologic testosterone on recipient safety and platelet function. The objective of this study was to provide a comprehensive profile of phenotype and function in platelets from TRT and control donors. Study Design and Methods Platelets in plasma were collected from TRT and control donors ( N = 10 per group; age‐ and sex‐matched) and stored at room temperature for 7 days. On storage Day 1 (D1) and Day 7 (D7), platelet products were analyzed for platelet count, metabolic parameters (i.e., glucose, lactate, mitochondrial function), surface receptor expression, aggregation, thrombin generation, and thrombus formation under physiological flow conditions.

Results

TRT donor platelets were not significantly different than control donor platelets in terms of count, surface phenotype, metabolic function, ability to aggregate, thrombin generation, or ability to form occlusive thrombus under arterial flow regimes. Both groups were similar to each other by D7, but had significantly lost hemostatic function compared to D1.

Discussion

Platelets derived from donors undergoing TRT have similar phenotypic and functional profiles compared to those derived from control donors. This suggests that therapeutic phlebotomy of TRT donors may provide a useful source for platelet products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneBlood PlateletsHormone Replacement TherapyBlood PreservationBlood DonorsHumansMalePhenotypeMiddle AgedAdultHemostasisFemale

Stichwörter der Autor:innen

blood component preparationshemostasistherapeutic apheresis

Substanzen

Testosterone

Autor:innen und Institutionen

  • Vitalant Research Institute, Denver, Colorado, USA.
  • Department of Pathology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, USA.

ORCID-Profile: Tamir Kanias, Kimberly A Thomas

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Chitrakar, A., Bean, S. M., Kanias, T., & Thomas, K. A. (2024). Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy. Transfusion. https://doi.org/10.1111/trf.17926

Vancouver

Chitrakar A, Bean SM, Kanias T, Thomas KA. Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy. Transfusion. 2024. doi:10.1111/trf.17926

BibTeX
@article{Chitrakar2024,
  author = {Chitrakar, Alisha and Bean, Scott-Wesley M and Kanias, Tamir and Thomas, Kimberly A},
  title = {Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17926}
}
Kostenlos starten →